CVE-2024-53522: n/a
CVE-2024-53522 is a high-severity vulnerability in Bangkok Medical Software HOSxP XE v4. 64. 11. 3 involving a hardcoded IDEA encryption Key-IV pair within executable and configuration components. This flaw allows remote attackers to decrypt sensitive information without authentication or user interaction, as the key is embedded in the software binaries. The vulnerability affects confidentiality but does not impact integrity or availability. Although no known exploits are currently reported in the wild, the ease of exploitation and the sensitive nature of medical data make this a critical concern. Organizations using this software should prioritize mitigation to prevent unauthorized data disclosure. No official patches are currently available, increasing the urgency for alternative protective measures. Countries with significant deployments of HOSxP XE, especially in Southeast Asia, are at higher risk.
AI Analysis
Technical Summary
CVE-2024-53522 identifies a vulnerability in Bangkok Medical Software's HOSxP XE version 4.64.11.3, where a hardcoded IDEA encryption key and initialization vector (IV) pair are embedded within the HOSxPXE4.exe executable and HOS-WIN32.INI configuration files. IDEA (International Data Encryption Algorithm) is a symmetric-key block cipher used to protect sensitive data. The presence of a hardcoded key-IV pair means that attackers who gain access to these components can decrypt encrypted data without needing additional credentials or user interaction. This vulnerability falls under CWE-331, which relates to the use of insufficiently protected credentials. The CVSS v3.1 base score is 7.5, indicating high severity, with an attack vector of network (AV:N), low attack complexity (AC:L), no privileges required (PR:N), and no user interaction (UI:N). The impact is primarily on confidentiality (C:H), with no impact on integrity (I:N) or availability (A:N). Although no exploits have been observed in the wild yet, the vulnerability poses a significant risk because medical software often handles highly sensitive patient information. The lack of available patches further complicates remediation efforts, necessitating immediate compensatory controls. The vulnerability was reserved in November 2024 and published in January 2025, reflecting recent discovery and disclosure.
Potential Impact
The primary impact of CVE-2024-53522 is unauthorized disclosure of sensitive patient information managed by the HOSxP XE medical software. Attackers exploiting this vulnerability can decrypt confidential data without authentication, potentially leading to privacy violations, regulatory non-compliance (e.g., HIPAA, GDPR), and reputational damage for healthcare providers. Since the vulnerability does not affect data integrity or system availability, the risk is focused on confidentiality breaches. The ease of exploitation over the network without privileges or user interaction increases the threat level, especially in environments where the software is exposed to untrusted networks or insufficiently segmented. The exposure of medical records can also facilitate further attacks such as identity theft, insurance fraud, or targeted phishing campaigns. Healthcare organizations worldwide that rely on HOSxP XE could face significant operational and legal consequences if this vulnerability is exploited.
Mitigation Recommendations
1. Immediate mitigation should include restricting network access to systems running HOSxP XE, especially blocking external access to the affected executables and configuration files. 2. Implement strict access controls and monitoring on endpoints hosting the software to detect unauthorized attempts to read or extract the hardcoded keys. 3. Employ network segmentation to isolate medical software systems from general-purpose networks and the internet. 4. Use host-based intrusion detection systems (HIDS) to alert on suspicious file access or process behavior related to HOSxPXE4.exe and HOS-WIN32.INI. 5. Encrypt sensitive data at rest and in transit using additional layers beyond the vulnerable IDEA encryption to reduce reliance on the compromised key. 6. Engage with the software vendor for timelines on official patches or updates and plan for rapid deployment once available. 7. Conduct regular audits and penetration testing focused on this vulnerability to assess exposure and effectiveness of mitigations. 8. Educate IT and security staff about this specific vulnerability to ensure prompt response to any related incidents.
Affected Countries
Thailand, Malaysia, Singapore, Vietnam, Indonesia, Philippines, United States, United Kingdom, Germany, Australia
CVE-2024-53522: n/a
Description
CVE-2024-53522 is a high-severity vulnerability in Bangkok Medical Software HOSxP XE v4. 64. 11. 3 involving a hardcoded IDEA encryption Key-IV pair within executable and configuration components. This flaw allows remote attackers to decrypt sensitive information without authentication or user interaction, as the key is embedded in the software binaries. The vulnerability affects confidentiality but does not impact integrity or availability. Although no known exploits are currently reported in the wild, the ease of exploitation and the sensitive nature of medical data make this a critical concern. Organizations using this software should prioritize mitigation to prevent unauthorized data disclosure. No official patches are currently available, increasing the urgency for alternative protective measures. Countries with significant deployments of HOSxP XE, especially in Southeast Asia, are at higher risk.
AI-Powered Analysis
Technical Analysis
CVE-2024-53522 identifies a vulnerability in Bangkok Medical Software's HOSxP XE version 4.64.11.3, where a hardcoded IDEA encryption key and initialization vector (IV) pair are embedded within the HOSxPXE4.exe executable and HOS-WIN32.INI configuration files. IDEA (International Data Encryption Algorithm) is a symmetric-key block cipher used to protect sensitive data. The presence of a hardcoded key-IV pair means that attackers who gain access to these components can decrypt encrypted data without needing additional credentials or user interaction. This vulnerability falls under CWE-331, which relates to the use of insufficiently protected credentials. The CVSS v3.1 base score is 7.5, indicating high severity, with an attack vector of network (AV:N), low attack complexity (AC:L), no privileges required (PR:N), and no user interaction (UI:N). The impact is primarily on confidentiality (C:H), with no impact on integrity (I:N) or availability (A:N). Although no exploits have been observed in the wild yet, the vulnerability poses a significant risk because medical software often handles highly sensitive patient information. The lack of available patches further complicates remediation efforts, necessitating immediate compensatory controls. The vulnerability was reserved in November 2024 and published in January 2025, reflecting recent discovery and disclosure.
Potential Impact
The primary impact of CVE-2024-53522 is unauthorized disclosure of sensitive patient information managed by the HOSxP XE medical software. Attackers exploiting this vulnerability can decrypt confidential data without authentication, potentially leading to privacy violations, regulatory non-compliance (e.g., HIPAA, GDPR), and reputational damage for healthcare providers. Since the vulnerability does not affect data integrity or system availability, the risk is focused on confidentiality breaches. The ease of exploitation over the network without privileges or user interaction increases the threat level, especially in environments where the software is exposed to untrusted networks or insufficiently segmented. The exposure of medical records can also facilitate further attacks such as identity theft, insurance fraud, or targeted phishing campaigns. Healthcare organizations worldwide that rely on HOSxP XE could face significant operational and legal consequences if this vulnerability is exploited.
Mitigation Recommendations
1. Immediate mitigation should include restricting network access to systems running HOSxP XE, especially blocking external access to the affected executables and configuration files. 2. Implement strict access controls and monitoring on endpoints hosting the software to detect unauthorized attempts to read or extract the hardcoded keys. 3. Employ network segmentation to isolate medical software systems from general-purpose networks and the internet. 4. Use host-based intrusion detection systems (HIDS) to alert on suspicious file access or process behavior related to HOSxPXE4.exe and HOS-WIN32.INI. 5. Encrypt sensitive data at rest and in transit using additional layers beyond the vulnerable IDEA encryption to reduce reliance on the compromised key. 6. Engage with the software vendor for timelines on official patches or updates and plan for rapid deployment once available. 7. Conduct regular audits and penetration testing focused on this vulnerability to assess exposure and effectiveness of mitigations. 8. Educate IT and security staff about this specific vulnerability to ensure prompt response to any related incidents.
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- mitre
- Date Reserved
- 2024-11-20T00:00:00.000Z
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 699f6bbfb7ef31ef0b55a9e3
Added to database: 2/25/2026, 9:38:07 PM
Last enriched: 2/26/2026, 1:45:25 AM
Last updated: 2/26/2026, 10:51:13 AM
Views: 2
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Related Threats
CVE-2025-64999: CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Checkmk GmbH Checkmk
HighCVE-2026-28138: Deserialization of Untrusted Data in Stylemix uListing
HighCVE-2026-28136: Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in VeronaLabs WP SMS
HighCVE-2026-28132: Improper Neutralization of Script-Related HTML Tags in a Web Page (Basic XSS) in villatheme WooCommerce Photo Reviews
HighCVE-2026-28131: Insertion of Sensitive Information Into Sent Data in WPVibes Elementor Addon Elements
HighActions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console in Console -> Billing for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.